Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

Overview of attention for article published in Nature Communications, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 17 X users

patent: 2 patents

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 59 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

IMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND…

Application WO-2023144723-A1

World Intellectual Property Organisation (WIPO)

IMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND…

Application WO-2022162549-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.